Insights from Industry RSS Feed - Insights from Industry

"Insights from Industry" is a dynamic series of interviews at the cutting edge of the medical industry. Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.
Eye donations: what stops people? An interview with Rory Passmore

Eye donations: what stops people? An interview with Rory Passmore

Despite a shortage of corneas for transplant purposes, our new research reveals that eyes are the one body part we are least likely to donate. [More]
The future of simulated teaching methods: an interview with Dr Robert Amyot

The future of simulated teaching methods: an interview with Dr Robert Amyot

In healthcare, we have physicians, nurses and paramedics who know the textbook by heart and know exactly what they need to do, but have never experienced the procedure first-hand, or they have no experience responding to adverse events that may occur. [More]
Could artificial intelligence help to combat stress? An interview with Davide Morelli

Could artificial intelligence help to combat stress? An interview with Davide Morelli

Stress is actually a bit of a buzzword. The initial definition was “the reaction to changes”, which is why you get stressed also when good things happen, hence the distinction between good stress, eustress, and bad stress, distress. [More]
New study identifies 40 genes susceptible to migraine

New study identifies 40 genes susceptible to migraine

Migraine is one of the most common neurological disorders and it affects 1 out of 7 people in the world. Painful and incapacitating, it has multi-factor origins, with the participation of environmental triggering factors and several altered genes in each individual. [More]
Molecular diagnostics of the future: an interview with Elaine Warburton, OBE

Molecular diagnostics of the future: an interview with Elaine Warburton, OBE

Firstly, a sample must be transported from the clinic to the laboratory. Simple tests may be undertaken in a small lab within the hospital or clinic, whilst complex testing such as drug susceptibility testing is often done in a large centralized laboratory many miles from the clinic [More]
Controlling corneal blindness by 2030: an interview with Dr Pravin Vaddavalli

Controlling corneal blindness by 2030: an interview with Dr Pravin Vaddavalli

Corneal blindness is estimated to be the second most prevalent cause of blindness in many less developed countries. Globally, bilateral corneal blindness is estimated to afflict 4.9 million persons and accounts for 12% of 39 million blind, utilizing WHO 2010 global blindness data. [More]
Medical applications of world’s smallest differential pressure sensor: an interview with Daniel Träutlein

Medical applications of world’s smallest differential pressure sensor: an interview with Daniel Träutlein

When Sensirion developed the first generation of differential pressure sensors (SDP1108 series), size was not of the essence. Instead Sensirion showed that it could provide, with the thermal flow through technique, a differential pressure sensor which is superior in performance, especially for low differential pressures. [More]
Using proteomic mass spectrometry imaging to detect malignant melanoma: an interview with Stephen Turner

Using proteomic mass spectrometry imaging to detect malignant melanoma: an interview with Stephen Turner

Today, using anatomic pathology, the differences in appearance of a normal or a malignant lesion can be difficult to tell when just using light microscopy. [More]
Portable breath sensor to detect lifestyle diseases? An interview with Osamu Tsuboi, Fujitsu Laboratories

Portable breath sensor to detect lifestyle diseases? An interview with Osamu Tsuboi, Fujitsu Laboratories

Generally, it is thought that there is a connection between concentrations of ammonia and liver disease, such as fatty liver and cirrhosis, Helicobacter pylori (H. pylori) infection, and kidney failure. [More]
Automated liquid handling in pharmaceutical research: an interview with Dr Alfred Chappell

Automated liquid handling in pharmaceutical research: an interview with Dr Alfred Chappell

In developing antisense therapeutics, scientists at Ionis evaluate thousands of oligonucleotides. One of my responsibilities is to oversee the QC and management of oligonucleotides used in target screening. [More]
Creating reference standards for cannabis testing: an interview with Adam Ross

Creating reference standards for cannabis testing: an interview with Adam Ross

The main applications for cannabis testing is to ensure that the product produced, whether the flower itself, tinctures, edibles, etc. contain acceptable levels of approved pesticide or other residues leftover from the growing or processing process. [More]
Tackling Zika: are insect repellents the answer? An interview with Bruno Jactel

Tackling Zika: are insect repellents the answer? An interview with Bruno Jactel

The repellents that are used today are mostly based on what we call chemical pesticides. These products are used to repel mosquitoes as well as ticks. They are very broadly used, but there are different issues surrounding their use. [More]
Empowering mobile health: an interview with Dr Rich Khatib and Dan Vahdat

Empowering mobile health: an interview with Dr Rich Khatib and Dan Vahdat

overview of Medopad and how you deliver patient information to mobile devices?
Medopad is a mobile health technology company. We focus on developing software within the mobile health industry. Mobile health, from our perspective, is an industry that really was invented with the iPad. [More]
Simultaneous DNA, RNA and protein analysis to enhance cancer immunology studies: an interview with Dr Joseph Beechem

Simultaneous DNA, RNA and protein analysis to enhance cancer immunology studies: an interview with Dr Joseph Beechem

Cancer immunology is all about how your immune cells are going to fight and kill your tumor cells. If you look at the pure genetic code of a T-cell that's going to kill your tumor compared to the same cell that has been “put-to-sleep” (by the tumor), the pure genetic DNA content of those two cells are identical. [More]
Guide to advance directives: an interview with Dr Lisa Price

Guide to advance directives: an interview with Dr Lisa Price

An advance directive is a very specific legal document that details the medical treatments you want, and, importantly, don’t want, if you’re unable to communicate with a physician. This may happen as a result of a critical illness that could make you confused or unable to speak. [More]
Advances in BioAFM: an interview with Dr. Thomas Mueller

Advances in BioAFM: an interview with Dr. Thomas Mueller

BioScope Resolve has enabled the first AFM images resolving individual microvilli on live cells. This is remarkable in that atomic force microscopy has been widely used to image live cells, and microvilli are often present. Yet the surface of those cells had remained featureless in AFM images. [More]
Spectral imaging technologies in microscopy: an interview with Alex Cooper

Spectral imaging technologies in microscopy: an interview with Alex Cooper

Spectral imaging encompasses two types of light control when using a microscope. Conventional microscopes use fluorescence excitation and emission filters, matched to fluorescent probes, in order to visualize specific organelles or processes within cells. [More]
Transforming MR images into body composition measurements: an interview with Olof Leinhard

Transforming MR images into body composition measurements: an interview with Olof Leinhard

Today's medical science utilizes relatively simple anthropometric measures that describe the body, such as body mass index (BMI) and waist circumference. All of these measures are approximations of the body with the intention to characterize what's inside reflecting underlying phenomena that underpin the risk for different diseases. [More]
Artificial intelligence in healthcare: an interview with Dr Ehud Reiter

Artificial intelligence in healthcare: an interview with Dr Ehud Reiter

Artificial Intelligence has made huge advances in recent years in many areas, including language processing, vision, and machine learning; we are also seeing the emergence of platforms that integrate different kinds of AI, such as IBM Watson (Arria is a Watson ecosystem partner). [More]
Reducing hair loss during chemotherapy: an interview with Richard Paxman

Reducing hair loss during chemotherapy: an interview with Richard Paxman

The basic principle of chemotherapy is to damage the mitotic and metabolic processes in the cancer cells. The chemotherapy doesn't just target the cancer cells, it also targets the healthy cells, specifically ones that are rapidly dividing - our hair follicles are also rapidly dividing. We see damage to those hair cells, which then causes the hair to fall out. [More]
Advertisement
Advertisement